Viewing Study NCT01627561


Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-02-05 @ 12:04 PM
Study NCT ID: NCT01627561
Status: COMPLETED
Last Update Posted: 2020-04-10
First Post: 2012-06-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infections, Papillomavirus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune response View
None Human papillomavirus View
None HPV vaccine View
None Safety View